The partnership, which aims to ensure integrity in sport by supporting high-quality, high-impact, novel research, was founded by the United States Olympic Committee (USOC), United States Anti-Doping Agency (USADA), Major League Baseball (MLB) and the National Football League (NFL).

Its focus is to make targeted grants in support of non-partisan and independent scientific research.

The PCC considers research that has a high likelihood of developing new methods and products that will advance the anti-doping field and ensure integrity in sport.

In addition to the five grants previously awarded by the PCC, the research conducted under six new grant awards will address the detection of a range of performance enhancing drugs and methods.

Recipients include Dr Barbara Daniel of King's College London; Dr James Rupert from the University of British Columbia; Dr Jason Dragoo of Stanford University; Dr Vanessa Agon, Dr Adam Cawley and Dr Catrin Goebel of the National Measurement Institute of Australia; Dr Anthony Butch of the University of California Los Angeles; and Dr Peter Van Eenoo from Ghent University.

The six grants total $1.3 million (£807,000) in funding, and bring the total number awarded since the PCC's inception to 11.

"The six new grants demonstrate the wide spectrum of anti-doping issues faced in sports and the potential impact of the PCC in addressing very pressing and timely topics," said PCC Board of Governors chairman Norman Bellingham.